| Application no. and date | 02793811.7 (espacenet) (Federated) (European Patent Register), 20021022 | | Patent/reg. no. and date | DK/EP 1444516, 20100721 | | Publication date | 20040811 | | Priority no. and date | US 336394 P, 20011022 | | EP pub. no. and date |
EP 1444516 20040811 | | Effective date | | | Applicant/owner | THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS
SYSTEM, 201 West 7th Street
Austin, Texas 78701, US,
Amgen, Inc., One Amgen Center Drive
Thousand Oaks, CA 91320-1799, US,
The Government of the United States of America,
represented by the Secretary, Department of Health and Human Services, 6011 Executive Boulevard,
Suite 325
Rockville, MD 20852-3804, US | | Applicant ref. no. | P81007366DK00E | | Inventor | DEPAOLI, Alex M., Amgen, Inc.,
One Amgen Center Drive
Thousand Oaks, CA 91320, US,
ORAL, Elif, Arioglu, National Institutes of Health
Bethesda, MD 20892, US,
TAYLOR, Simeon I., Eli Lilly and Company,
Lilly Corporate Center
Indianapolis, IN 46285, US,
GARG, A.,
Univ. Texas Southwestern Medical Centre, 5323 Harry Hines Boulevard
Dallas, TX 57390, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 38/18 (2006.01) , A61K 38/19 (2006.01) , A61P 3/06 (2006.01) , A61P 3/10 (2006.01) , G01N 33/53 (2006.01) | | Title | Anvendelse af leptin til behandling af lipoatrofi hos mennesker og fremgangsmåde til at bestemme en prædisposition for denne behandling | | Int. application no. | US2002033875 | | Int. publication no. | WO2003034996 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
